Walgreens Spearheads Advancement of Cell and Gene Therapies in Patient Care Expansion

Walgreens announces expansion into cell and gene therapy services in the U.S., aiming to provide specialized care for patients with chronic, rare, or complex conditions. The move includes the launch of a new business unit and the opening of a facility in Pittsburgh dedicated to cell and gene therapies, reflecting the growing importance of specialty pharmacies in the healthcare system. [ad_1] A person rides past a Walgreens truck, owned by the Walgreens Boots Alliance, in Manhattan, New York City, on Nov. 26, 2021. Andrew Kelly | Reuters Walgreens on Thursday said…

Walgreens tops quarterly revenue estimates, but narrows profit outlook in 'challenging' economy

[ad_1] A person rides past a Walgreens truck, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York City, U.S., November 26, 2021.  Andrew Kelly | Reuters Walgreens on Thursday reported fiscal second-quarter sales that beat Wall Street’s expectations, but lowered the high end of its full-year adjusted earnings outlook in part due to a “challenging” retail environment in the U.S. The company also posted a steep net loss for the quarter as it recorded a hefty nearly $6 billion charge related to the decline in value of its…